Somatostatin receptor subtypes 2 and 5 are associated with better survival in operable hepatitis B-related hepatocellular carcinoma following octreotide long-acting release treatment
Liver resections for hepatocellular carcinoma (HCC) in cirrhotic livers are associated with early recurrence and poor survival. Somatostatin analogues (SSAs) have been reported to inhibit cell proliferation by interacting with specific somatostatin receptors (SSTRs) 2 and 5. The present study invest...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
D.A. Spandidos
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789087/ |